Metastasis-directed therapy added to ADT helps slow the progression of metastatic prostate cancer, a phase 2 trial finds. The addition of metastasis-directed therapy (MDT) to androgen deprivation ...

SGLT2 inhibitors linked to lower hormone therapy failure in prostate cancer. Learn more about their potential role in improving treatment outcomes.

A diet rich in vegetables and probiotics could help slow the growth of low-risk prostate cancer, a new study suggests. Researchers found that specially designed supplements and probiotics appeared to ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Probiotics and broccoli could help to slow the spread of prostate cancer, research suggests. Broccoli, turmeric, pomegranate, ...

Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or ...

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...